Hyperlipoproteinemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
* [[Fibrate]] | * [[Fibrate]] | ||
* [[Omega-3 fatty acids]] | * [[Omega-3 fatty acids]] | ||
===Trial supportive data=== | |||
====[[Niacin]]==== | |||
=====[[Niacin AIM HIGH study | AIM HIGH study]]===== | |||
==References== | ==References== | ||
Revision as of 14:53, 24 August 2012
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]